Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leukemia circulation kinetics revealed through blood exchange method.
Miller AB, Rodriguez FH, Langenbucher A, Lin L, Bray C, Duquette S, Zhang Y, Goulet D, Lane AA, Weinstock DM, Hemann MT, Manalis SR. Miller AB, et al. Commun Biol. 2024 Apr 20;7(1):483. doi: 10.1038/s42003-024-06181-x. Commun Biol. 2024. PMID: 38643279 Free PMC article.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Daver NG, Montesinos P, DeAngelo DJ, Wang ES, Papadantonakis N, Todisco E, Sweet KL, Pemmaraju N, Lane AA, Torres-Miñana L, Thompson JE, Konopleva MY, Sloss CM, Watkins K, Bedse G, Du Y, Malcolm KE, Zweidler-McKay PA, Kantarjian HM. Daver NG, et al. Lancet Oncol. 2024 Mar;25(3):388-399. doi: 10.1016/S1470-2045(23)00674-5. Lancet Oncol. 2024. PMID: 38423051 Clinical Trial.
Targetable leukemia dependency on noncanonical PI3Kγ signaling.
Luo Q, Raulston EG, Prado MA, Wu X, Gritsman K, Yan K, Booth CAG, Xu R, van Galen P, Doench JG, Shimony S, Long HW, Neuberg DS, Paulo JA, Lane AA. Luo Q, et al. bioRxiv [Preprint]. 2023 Dec 15:2023.12.15.571909. doi: 10.1101/2023.12.15.571909. bioRxiv. 2023. PMID: 38328043 Free PMC article. Preprint.
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
Lane AA, Garcia JS, Raulston EG, Garzon JL, Galinsky I, Baxter EW, Leonard R, DeAngelo DJ, Luskin MR, Reilly CR, Stahl M, Stone RM, Vedula RS, Wadleigh MM, Winer ES, Mughal T, Brooks C, Gupta IV, Stevenson KE, Neuberg DS, Ren S, Keating J, Konopleva M, Stein A, Pemmaraju N. Lane AA, et al. Blood Adv. 2024 Feb 13;8(3):591-602. doi: 10.1182/bloodadvances.2023011721. Blood Adv. 2024. PMID: 38052038 Free PMC article. Clinical Trial.
AMPK activation induces immunogenic cell death in AML.
Mondesir J, Ghisi M, Poillet L, Bossong RA, Kepp O, Kroemer G, Sarry JE, Tamburini J, Lane AA. Mondesir J, et al. Blood Adv. 2023 Dec 26;7(24):7585-7596. doi: 10.1182/bloodadvances.2022009444. Blood Adv. 2023. PMID: 37903311 Free PMC article.
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S, DeAngelo DJ, Garcia JS, Hasserjian RP, Hergott CB, Lane AA, Lovitch SB, Lucas F, Luskin MR, Morgan EA, Pinkus GS, Pozdnyakova O, Rodig SJ, Shanmugam V, Tsai HK, Winer ES, Zemmour D, Kim AS. Sadigh S, et al. Mod Pathol. 2024 Jan;37(1):100352. doi: 10.1016/j.modpat.2023.100352. Epub 2023 Oct 13. Mod Pathol. 2024. PMID: 37839675
DDX41: here, there…and everywhere.
Reilly CR, Lane AA. Reilly CR, et al. Blood. 2023 Oct 5;142(14):1177-1178. doi: 10.1182/blood.2023021850. Blood. 2023. PMID: 37796519 No abstract available.
Enhancing dendritic cells by inhibiting BCL2.
Booth CAG, Lane AA. Booth CAG, et al. Trends Cancer. 2023 Dec;9(12):987-988. doi: 10.1016/j.trecan.2023.09.007. Epub 2023 Sep 30. Trends Cancer. 2023. PMID: 37783616
90 results